§
Luxuse
Patent Intelligence
Sign In
← Back to Patent Explorer
US4510924A Expired / Lapsed US ⏱️ 0.0 years remaining

Brachytherapy devices and methods employing americium-241

Assignee: Yale New Haven Hospital
•
Filing: 1983-01-13
•
Granted: 1985-04-16
•
Expires: 2003-01-13
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Sources and methods for radiation therapy, particularly brachytherapy, employing americium-241 radioisotope. The physical properties of americium-241 (60 keV gamma emission and 433 year half-life) provide major advantages for radiotherapy, including simplified radiation protection, dose reduction to healthy tissue, increased dose to tumor, and improved dose distributions. A number of apparent drawbacks and unfavorable considerations including low gamma factor, high self-absorption, increased activity required and alpha-particle generation leading to helium gas pressure buildup and potential neutron contamination in the generated radiation are all effectively dealt with and overcome through recognition of subtle favorable factors unique to americium-241 among brachytherapy sources and through suitable constructional techniques. Due to an additional amount of radiation, in the order of 50%, provided primarily to nearby regions as a result of Compton scatter in tissue and water, higher dose rates occur than would be predicted by conventional calculations.

Inventors

  • 👤 Laurence A. Gray

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 10:49
CPC Classifications
A; A61; A61N; A61N5/00; A61N5/10; A61N5/1001; A61N5/1027; A61N2005/1019; A61N2005/1024; A61N2005/1085; A61N2005/109

Claims Analysis

Total Claims: 10
Claim 1
Independent Claim 100 words
A radiation source for brachytherapy consisting essentially of: a sealed capsule having a cavity therein; and a brachytherapeutically effective quantity of americium-241 radioisotope disposed within said cavity, wherein the walls of said capsule consist essentially of a material having a thickness which (1) will transmit brachytherapeutically effective dosages of gamma radiation generated by said quantity of americium-241 and, (2) will contain the helium gas resulting from the decay of the alpha particles generated by said quantity of americium-241, and (3) which provides a neutron component of no more than approximately 1% of the total radiation dose provided by said source.
Claim 2
Dependent Claim 100 words
A radiation source for brachytherapy consisting essentially of: a sealed capsule having a cavity therein; and a brachytherapeutically effective quantity of americium-241 radioisotope disposed within said cavity, wherein the walls of said capsule consist essentially of a material having a thickness which (1) will transmit brachytherapeutically effective dosages of gamma radiation generated by said quantity of americium-241 and, (2) will contain the helium gas resulting from the decay of the alpha particles generated by said quantity of americium-241, and (3) which provides a neutron component of no more than approximately 1% of the total radiation dose provided by said source.
Claim 3
Dependent Claim 17 words
A radiation source for brachytherapy according to claim 1 wherein said capsule wall consists essentially of titanium.
Claim 4
Dependent Claim 23 words
A radiation source for brachytherapy according to claim 1, wherein said quantity of americium-241 radioisotope is in the form of americium-241 oxide powder.
Claim 5
Dependent Claim 23 words
A radiation source for brachytherapy according to claim 1, wherein said quantity of americium-241 radioisotope is in the form of a ceramic enamel.
Claim 6
Dependent Claim 22 words
A radiation source for brachytherapy according to claim 1, wherein said capsule also includes a reservoir to alleviate helium gas pressure buildup.
Claim 7
Dependent Claim 34 words
A radiation source for brachytherapy according to claim 1, wherein said quantity of americium-241 radioisotope is provided in loosely-packed powder form with reservoir spaces between the particles thereof to alleviate helium gas pressure buildup.
Claim 8
Dependent Claim 25 words
A radiation source for brachytherapy according to claim 1, wherein said quantity of americium-241 radioisotope is in the form of a mass of cylindrical configuration.
Claim 9
Dependent Claim 28 words
A radiation source for brachytherapy according to claim 7, wherein a hollow reservoir is included within said cylindrical mass of americium-241 radioisotope to alleviate helium gas pressure buildup.
Claim 10
Dependent Claim 33 words
A radiation source for brachytherapy according to claim 1, wherein said capsule also includes a gamma-radiation shielding layer on a portion of said capsule to modify the gamma-radiation pattern provided by said course.

References Cited (Backward Citations)

US3488502A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1988-04-15 1988-10-15 1989-04-16 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1992-04-15 1992-10-15 1993-04-16 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1996-04-15 1996-10-15 1997-04-16 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag